Trial · NCT07911943
Comparison of Analgesic Efficacy Between Ultrasound Guided Serratus Anterior Plane Block or Thoracic Paravertebral Block Versus Intravenous Fentanyl for On-pump Coronary Artery Bypass Graft Surgery
NCT07911943, Phase 1, Active not recruiting, Ain Shams University
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Comparison of Analgesic Efficacy Between Ultrasound Guided Serratus Anterior Plane Block or Thoracic Paravertebral Block Versus Intravenous Fentanyl for On-pump Coronary Artery Bypass Graft Surgery. Trials, record NCT07911943. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07911943
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Comparison of Analgesic Efficacy Between Ultrasound Guided Serratus Anterior Plane Block or Thoracic Paravertebral Block Versus Intravenous Fentanyl for On-pump Coronary Artery Bypass Graft Surgery
- NCT number
- NCT07911943
- Status
- Active not recruiting
- Phases
- Phase 1
- Enrollment
- 111 participants, estimated
- Lead sponsor
- Ain Shams University
- Conditions
- Intra and Post Operative Pain Management, Fast Track Program,(Enhanced Recovery After Surgery (ERAS))
- Interventions
- Serratus Anterior Plane Block (SAPB) group, Thoracic paravertebral block (TPVB), Intravenous fentanyl 1 μg∙kg-1
- First posted
- 2026-11-03
- Last updated
- 2026-11-12
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Duration of analgesia in hours | up to 12 hours | |
| Primary | Postoperative visual analogue pain score | up to 12 hours | Postoperative visual analogue pain score: It will be recorded every 1 hour after admission to ICU for the first 4 hours ' then every 2 hours for the remaining 8 hours. The resulting measurement in millimeters gives a continuous score from 0 to 100 0-4 mm: No pain 5-44 mm: Mild pain 45-74 mm: Moderate pain 75-100 mm: Severe pain |
| Primary | Total dose of fentanyl | up to 18 hours | Total doses of intra , postoperative fentanyl consumption and doses of rescue fentanyl. |
| Secondary | Intra and postoperative haemodynamic data | up to 18 hours | Mean blood pressure (mmHg): Baseline, immediately after performing the block, at 30 minutes intervals (except when the patient on CPB) till the end of surgery Mean blood pressure (mmHg): Immediately after ICU admission, at 1 hour intervals in the 1st 6 hours, then at 2 hours intervals till 12 hours |
| Secondary | Postoperative extubation time | for 12 hours | Postoperative extubation time in minutes. |
| Secondary | Patients with block-related side effects and complications | for 3 days | bleeding , hematoma , inflammation , nerve injury , hemodynamic changes |
| Secondary | Pulmonary function assessment | for 12 hours | Pulmonary function assessment \[forced expiratory volume at one second as % of predicted) using spirometry: Every 6 hours after extubation up to 12 hours |
| Secondary | Intra and postoperative haemodynamic data. Heart rate | up to 18 hours | Heart rate (beats/minute): Baseline, immediately after performing the block, at 30 minutes intervals (except when the patient on CPB) till the end of surgery Heart rate (beats/minute): Immediately after ICU admission, at 1 hour intervals in the 1st 6 hours, then at 2 hours intervals till 12 hours |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers10
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07911943
GET https://conductscience.org/api/trials/v1/NCT07911943/registered